Evidence map›Paper›PMID 41807428›Full record

ArticleScientific data2026

Human neuronal differentiation under Aβ exposure: a single-cell transcriptomic and epigenomic dataset.

Idoia Blanco-Luquin, Xabier Martínez-de-Morentin, Amaia Vilas-Zornoza, Daniel Mouzo, Alejandro Lumbreras Lopez, Mónica Macías, Diego Alignani, Alberto Maillo, Ana Cecilia Gonzalez Alvarez, Leena Ali Ibrahim and 6 more

Abstract readDataset
In one paragraph

Article in Scientific data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Idoia Blanco-Luquin *Neuroepigenetics Unit-Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA (Navarra Institute for Health Research), C/ Irunlarrea, 3, Pamplona, Navarra, 31008, Spain. iblancol@navarra.es.
Xabier Martínez-de-Morentin *Division of Biomedical Sciences, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Saudi Arabia. xabier.iribarren@kaust.edu.sa.ORCID http://orcid.org/0000-0002-8358-9214
Amaia Vilas-ZornozaAdvanced Genomics Laboratory, Program of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Daniel MouzoCentre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.
Alejandro Lumbreras LopezNeuroepigenetics Unit-Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA (Navarra Institute for Health Research), C/ Irunlarrea, 3, Pamplona, Navarra, 31008, Spain.
Mónica MacíasNeuroepigenetics Unit-Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA (Navarra Institute for Health Research), C/ Irunlarrea, 3, Pamplona, Navarra, 31008, Spain.
Diego AlignaniHemato-Oncology Program, Center for Applied Medical Research (CIMA), IDISNA, University of Navarra, Pamplona, Spain.
Alberto MailloDivision of Biomedical Sciences, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Saudi Arabia.
Ana Cecilia Gonzalez AlvarezDivision of Biomedical Sciences, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Saudi Arabia.
Leena Ali IbrahimDivision of Biomedical Sciences, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Saudi Arabia.ORCID http://orcid.org/0000-0001-8255-3423
Vincenzo LaganiDivision of Biomedical Sciences, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Saudi Arabia.
Natalia RamírezOncohematology Research Group, Navarrabiomed, University Hospital of Navarra, Public University of Navarra, Navarra Medical Research Institute (IdiSNA), Pamplona, Spain.
Jesper TegnerDivision of Biomedical Sciences, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Saudi Arabia.ORCID http://orcid.org/0000-0002-9568-5588
Felipe PrósperAdvanced Genomics Laboratory, Program of Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.
Maite MendiorozNeuroepigenetics Unit-Navarrabiomed, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA (Navarra Institute for Health Research), C/ Irunlarrea, 3, Pamplona, Navarra, 31008, Spain. tmendioi@navarra.es.
David Gomez-CabreroDivision of Biomedical Sciences, King Abdullah University of Science and Technology (KAUST), Thuwal, 23955, Saudi Arabia. david.gomezcabrero@kaust.edu.sa.ORCID http://orcid.org/0000-0003-4186-3788

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human induced pluripotent stem cell-derived neural progenitor cells (NPCs) provide a controlled in-vitro model for studying early stages of neuronal differentiation. Here, we present a multimodal single-cell dataset generated from NPCs differentiated over four time points (days 0, 7, 13 and 20) under baseline conditions and following exposure to amyloid-β (Aβ) 1-42 peptide. The dataset comprises paired single-cell RNA sequencing (scRNA-seq) and single-cell ATAC sequencing (scATAC-seq) profiles, enabling joint characterization of transcriptional and chromatin accessibility dynamics during differentiation. Following stringent quality control, we analyzed 42575 and 30192 high-quality cells for RNA and ATAC respectively, providing an in-depth characterization of cell composition, molecular signaling pathways, functional properties, and gene regulatory network annotations. To facilitate reuse and benchmarking, transcriptional signatures derived from this dataset were additionally compared with a publicly available human hippocampal bulk RNA-seq dataset. This resource provides a reference multimodal dataset for human NPC-derived neuronal differentiation and supports a broad range of single-cell, multimodal integration, and regulatory network analyses.

Indexed as

Amyloid beta-PeptidesCell DifferentiationNeural Stem CellsNeuronsTranscriptomeEpigenomicsHumansInduced Pluripotent Stem CellsSequence Analysis, RNASingle-Cell AnalysisSingle-Cell Gene Expression AnalysisAmyloid beta-Peptides

Identifiers

PMID41807428
PMCPMC13103403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.